福瑞达：瑷尔博士处于战略调整期，颐莲喷雾品线官宣新代言人销量同比增长69%

Group 1 - The core viewpoint of the news is that the company is focusing on innovation and brand development in the cosmetics sector, achieving significant revenue growth and maintaining a strong market position [1][2][4] - In Q1 2025, the cosmetics segment generated revenue of 526 million yuan with a gross margin of 61.06%, driven by key brands such as Yilian and Aier Doctor, which achieved revenues of 250 million yuan and 236 million yuan respectively [1] - The company launched 47 new products and obtained 12 new patents in the cosmetics segment during the reporting period, emphasizing a research-driven approach and technological innovation [1][2] Group 2 - The company is committed to a dual-brand strategy focusing on Yilian and Aier Doctor while optimizing the operations of other brands, transitioning from a single beauty business to a "beauty + medical beauty" model [3] - The company plans to enhance its core competitiveness through continuous R&D investment, with a projected R&D expenditure of 199 million yuan in 2024 and approximately 42 million yuan in Q1 2025 [2] - The company is advancing its product lines and brand strategies, including the introduction of innovative products and technologies, such as the membrane collagen technology launched by the Kemi brand [4]